![]() |
|
|
Forward to a colleague |
||
Access Full Stories The world's generics titan, Teva, has reportedly earmarked over $1bn to fuel an ambitious plan to broaden its presence in India... Read Into Africa - Roche expands HIV tech transfer Roche today announced a handful of new charitable technology transfer agreements with manufacturers in Africa and Asia, allowing local production of generic HIV drugs... Read India attracts Japan's number two pharma Japan's number two pharma firm has elected to set up significant operations in India - the first Japanese pharma company planning to plant itself in the country on such a scale... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving Encorium Group, Holmes Biopharma and Novotech... Read US CRO hosting free oncolcogy trial seminars A series of free educational/networking evenings are planned across the US, addressing some of the most pressing issues and new developments in oncology clinical trials... Read |
|||||||||||||
All News Headlines for: January | December | November |
|||||||||||||
![]() DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here | |||||||||||||
|
Related Industry News US approval for once daily Cialis Eli Lilly's once-a-day version of its erectile dysfunction (ED) treatment Cialis (tadalafil) has finally got the go ahead from US regulators, six months after approval in the EU... Read Crucell, Sanofi mix it up with rabies cocktail deal Dutch firm Crucell last week announced that it has entered into an agreement with vaccine specialist Sanofi Pasteur for its next generation rabies antibody cocktail... Read New drug target leaves lung cancer cells alone, lonely and dying It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own... Read A drug cocktail to bust brain tumours A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis... Read
|
|||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||